Point of View | 01.03.18 “The NIH is in danger of losing its edge in creating biomedical innovations” OpEd published in STAT News
Research Update | 11.20.17 CD22 CAR-T Therapy Shows Results in Leukemia, Study Shows, But Could a Dual CAR-T Deliver the One-Two Punch to Avoid Relapse?
Press Release | 11.14.17 Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Research Update | 11.02.17 Higher Diversity of Gut Microbes, More Faecalibacteria Linked to Better Response to Cancer Immunotherapy, Study Shows
Announcement, Research Update | 10.31.17 Parker Institute for Cancer Immunotherapy Researchers Present Findings on Pancreatic Cancer, Tumor Vaccines and CAR-T at 2017 Society for Immunotherapy of Cancer Annual Meeting
Press Release | 10.16.17 Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy